Agilent Technologies enters definitive agreement to acquire Proscia
A•Agilent Technologies agreed to acquire Proscia in an all-cash transaction valued at $240 million, plus up to $30 million tied to future performance milestones.
1. Deal terms
Agilent said Proscia will become part of its Life Sciences & Diagnostics Markets Group upon closing. The all-cash deal is valued at $240 million, with an additional $30 million based on achieving future performance milestones.
